P5-19-05: Age-Related Changes in the Pharmacokinetics (pK), Response, and Toxicity of Weekly nab-Paclitaxel in Patients with Metastatic Breast Cancer (MBC).
Arti Hurria(Unknown), George Somlo(City Of Hope National Medical Center), Bryan Williams(The London College), Jaycen Brown(City of Hope), Reena Jayani(Vanderbilt University Medical Center), Katherine Hansen, T Luu(City of Hope), Carol Wong(City of Hope), Arnold Rotter(City of Hope), Vani Katheria(City of Hope), Christopher Chung(Gynecologic Oncology Group), Suzette Blanchard(Rutgers, The State University of New Jersey), Joanne Mortimer(City of Hope), Rupal Ramani, Timothy W. Synold(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.4k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k